Ranbaxy Recalls Generic Lipitor In US For Possible Presence Of Glass Particle
By Sreeja V N | November 23, 2012 10:02 PM EST
Ranbaxy Laboratories Ltd, India’s largest drug manufacturer by sales, has announced a voluntary recall of its cholesterol-lowering generic drug -- Lipitor -- from the U.S. market.
Ranbaxy’s U.S. wing, Ranbaxy Pharmaceuticals Inc, has recalled various batches of the Atorvastatin calcium tablets -- a generic version of the Lipitor drug -- from the market, the company has said in a statement.
“Ranbaxy Pharmaceuticals Inc. is conducting a voluntary recall for Atorvastatin calcium tablets, in connection with its 10mg 20mg and 40mg dosage strengths, packaged in 90’s and 500 count bottles and only with respect to certain select lot numbers. The recall does not affect or relate to the 80mg strength,” according to a statement on the company’s website.
Ranbaxy was the first company to launch the generic version of the Lipitor after Pfizer Inc's patent expired in November, 2011. The drug was responsible for generating $600 million in sales for the company.
Ranbaxy had compliance issues with the U.S. Food and Drug Administration (FDA) in the past. The FDA banned shipments from some of Ranbaxy’s manufacturing units in 2009 following which the company agreed to take corrective steps in its plants, Reuters reported.
However, industry experts have said that the current recall indicates that such corrective measures are not adequate and the recall will affect the company’s revenues.
"The development will impact the company's credibility to an extent," said Bhagwan Singh Chaudhary, a research associate at the brokerage IndiaNivesh
"There have been issues in the past (about compliance) and a recall suggests, corrective measures suggested by the US FDA are not being implemented," he added, according to Reuters.
However, Ranbaxy said that the recall was being done keeping customers’ safety in mind and the FDA had full knowledge of the issue.
“The recall is being conducted at the retail level for such select batches that may contain a foreign substance (small glass particles approximately less than 1mm in size). Ranbaxy is proactively recalling the drug product lots out of an abundance of caution, and in keeping the safety of our customers in mind. This recall is being conducted with the full knowledge of the U.S. FDA,” the company said.
Click here for the complete list of the batches of drug being recalled.
To contact the editor, e-mail:
Most Popular Slideshows
- Pope Francis Meets Sudanese Woman Who Was Spared Death for Apostasy (PHOTOS)
- Malaysia Airlines Flight MH17: King Williem-Alexander, Queen Maxima Hold Solemn Reception Ceremony for Victims
- Jennifer Lawrence & Nicholas Hoult Allegedly Split: Mad Max Actor Cheats with Kristen Stewart & Riley Keough - Reports
- Transfer News: FC Barcelona Shockingly Sign Valencia Defender [PHOTOS]
Join the Conversation
- Mad Max Fury Road Film Trailer from Aussie Director George Miller Shown at 2014 Comic-Con in San Diego: Tom Hardy Replaces Mel Gibson! [WATCH VIDEO]
- Scandal Season 4 Update: Premiere Episode Title Revealed, A Different New Season
- ‘The Voice Australia’ Winner Anja Nissen Explains Why She Scrapped Delta Goodrem’s Song
- The Bachelor Australia: Blake Garvey Talks Adventurous Past, Season 2 First Look [VIDEO]
- 2014 Meteor Shower: Where to Watch Delta Aquarids July 28-29 Peak Online, NASA Cameras Spotted Start of Perseid Meteor Shower
- Apple iPhone 6 on Two Confirmed Release Dates, New Parts Leaked Suggesting Bigger iPhone to Come
- Xiaomi Mi4 vs OnePlusOne vs Nexus 5: Mi4 is the ‘Perfect’ Phone
- Google Nexus 6, 8 with Android L on Release Date Promises Killer Mobile Device Experience
- Israeli Women Stripping Naked for IDF Soldiers
- HTC One M8 Android 4.4.3 KitKat Update Roll Out, Introducing the HTC One Remix
- Shocking Video of Pedigree Dog Culling in Bali Emerges [Video]
- Sony Xperia Z3 Specs Leaked with More Killer Features Ahead of Samsung Galaxy Note 4, iPhone 6